LT - 2,3,4,9-tetrahidro-1H-karbazolo dariniai, kaip CRTH2 receptoriaus antagonistai
EN - 2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 209/88 |
(2006.01) |
|
|
A61K 31/404 |
(2006.01) |
|
|
A61P 37/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
1833791 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
05850906.8 |
|
Date of filing the European patent application |
2005-12-22 |
| (97) |
Date of publication of the European application |
2007-09-19 |
| (45) |
Date of publication and mention of the grant of the patent |
2011-08-03
|
| (46) |
Date of publication of the claims translation |
2011-11-25
|
PCT application
| (86) |
Number |
PCT/IB2005/054380 |
|
Date |
2005-12-22 |
PCT application publication
| (87) |
Number |
WO 2006/070325 |
|
Date |
2006-07-06 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
PCT/EP2004/0147 |
2004-12-27
|
WO |
Inventors
| (72) |
FECHER, Anja, CH
FRETZ, Heinz, CH
RIEDERER, Markus, CH
|
Grantee
| (73) |
Actelion Pharmaceuticals Ltd.,
Gewerbestrasse 16, 4123 Allschwil,
CH
|
Attorney or representative
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
2,3,4,9-tetrahidro-1H-karbazolo dariniai, kaip CRTH2 receptoriaus antagonistai |
| |
2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2012-11-22 |
8 |
640.00
LTL
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2013-12-22 |
